An Australian company developing a chronic pain treatment based on research at The University of Queensland (UQ) has attracted US$45 million (AU$48M) to advance development of the drug, EMA401.
11 April 2014Search UQ News
An Australian company developing a chronic pain treatment based on research at The University of Queensland (UQ) has attracted US$45 million (AU$48M) to advance development of the drug, EMA401.
11 April 2014
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B